Speculation on gene therapy trial death ‘premature’

August 9, 2007

Targeted Genetics said it was “premature as well as irresponsible” to draw any conclusions on what caused the death of a patient who participated in a clinical trial testing the safety of the firm’s new gene therapy. (US-Pharma)